Literature DB >> 20981676

Effective use of rituximab for acquired amegakaryocytic thrombocytopenia.

Dries Deeren, Jo Van Dorpe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20981676     DOI： 10.1002/ajh.21882

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up.

Authors:  Mehrzad Mirzania; Sedigheh Khalili; Akbar Hasanpoor; Ahmad Reza Shamshiri
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014

2.  Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia: A Case Report.

Authors:  Arya Mariam Roy; Manojna Konda; George K Sidarous; Dinesh Atwal; Steven A Schichman; Anuradha Kunthur
Journal:  Perm J       Date:  2020-12

3.  "Almost bleeding to death": the conundrum of acquired amegakaryocytic thrombocytopenia.

Authors:  Gabrielle Elena Brown; Hani M Babiker; Carlos L Cantu; Andrew M Yeager; Ravitharan Krishnadasan
Journal:  Case Rep Hematol       Date:  2014-02-06

4.  Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia in Thymoma.

Authors:  Sumit Dahal; Eliza Sharma; Suyash Dahal; Binav Shrestha; Bikash Bhattarai
Journal:  Case Rep Hematol       Date:  2018-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.